Oxytocin Receptor in Cerebellar Purkinje Cells Does Not Engage in Autism-Related Behaviors.

Scientists studied whether oxytocin (a hormone sometimes used to help with autism symptoms) works through a specific part of the brain called the cerebellum. They found that oxytocin doesn't seem to affect this brain area in ways that would help with autism symptoms. This research helps scientists better understand how oxytocin might work as a treatment for autism.

This preclinical study investigated whether oxytocin receptors in cerebellar Purkinje cells contribute to autism-related behaviors. Researchers found oxytocin receptors in Purkinje cells of cerebellar lobule Crus I, an area connected to autism-implicated brain circuits. However, oxytocin activation did not affect normal Purkinje cell function or improve abnormalities in a maternal immune activation mouse model of autism. Additionally, blocking oxytocin receptors in this brain region did not induce autism-like behaviors in normal mice.

The findings suggest that oxytocin's therapeutic effects in autism spectrum disorders may not involve this specific cerebellar pathway, providing important insights into understanding oxytocin's mechanisms of action in autism treatment.

Results suggest oxytocin's therapeutic effects in autism may not involve cerebellar Purkinje cell pathways. This helps narrow the focus for understanding oxytocin mechanisms and may guide development of more targeted therapeutic approaches for autism spectrum disorders.

Study conducted only in mouse models, which may not fully translate to human autism. Sample size not reported. Limited to one specific cerebellar region and may not represent broader cerebellar or oxytocin system function.

The classical motor center cerebellum is one of the most consistent structures of abnormality in autism spectrum disorders (ASD), and neuropeptide oxytocin is increasingly explored as a potential pharmacotherapy for ASD. However, whether oxytocin targets the cerebellum for therapeutic effects remains unclear. Here, we report a localization of oxytocin receptor (OXTR) in Purkinje cells (PCs) of cerebellar lobule Crus I, which is functionally connected with ASD-implicated circuits. OXTR activation neither affects firing activities, intrinsic excitability, and synaptic transmission of normal PCs nor improves abnormal intrinsic excitability and synaptic transmission of PCs in maternal immune activation (MIA) mouse model of autism.

Furthermore, blockage of OXTR in Crus I in wild-type mice does not induce autistic-like social, stereotypic, cognitive, and anxiety-like behaviors. These results suggest that oxytocin signaling in Crus I PCs seems to be uninvolved in ASD pathophysiology, and contribute to understanding of targets and mechanisms of oxytocin in ASD treatment.